OpenAlex
PricingAboutJobs
Log inGet started
Work

Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma

HTML

Year: 2013
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-13-0011
Authors: Matteo S. Carlino, Kavitha Gowrishankar, Catherine A.B. Saunders, Gulietta M. Pupo, Stephanie Snoyman, Xu Dong Zhang, Robyn Saw, Therese M. Becker, Richard F. Kefford, Georgina V. Long, Helen Rizos
Institutions: The University of Sydney, Westmead Hospital, Melanoma Institute Australia, University of Newcastle Australia
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: melanoma, BRAF-mutant melanoma, MAPK inhibitors, dabrafenib, trametinib, acquired drug resistance, antiproliferative activity, cyclin D1, retinoblastoma protein, S-phase inhibition, MAPK signaling
SDG: Good health and well-being

Open Access status: closed

Funders: University of Sydney, Melanoma Institute Australia
OpenAlex ID: W2139707889
FWCI: 3.557
Cites: 47
Cited by: 85
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security